Petrelintide

N/A

Report date: 2026/05/18 20:02:07

Base Information

Drug NamePetrelintide
Drug Alias Namelong-acting amylin analog长效胰淀素类似物ZP-8396ZP8396
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionIslet amyloid polypeptide replacements
TargetsIslet amyloid polypeptide
Therapy Area/IndicationsOverweightObesityDiabetes Mellitus, Type 2 +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandRomania +[5
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesZealand Pharma A/S
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsOverweightObesityDiabetes Mellitus, Type 2 +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A